The aim of this study is to investigate the chemopreventive effects of the synthetic phenolic
antioxidant 1-O-hexyl-2,3, 5-trimethylhydroquinone (HTHQ) on 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (
PhIP)-associated colon
carcinogenesis in rats after initiation with
1,2-dimethylhydrazine (
DMH) in male F344 rats. Groups of 20-22, 6-week-old male F344 rats were given four
subcutaneous injections of 40 mg/kg body wt of
DMH during the initial 4 weeks. They were then maintained on powdered basal diet containing 0.03%
PhIP alone,
PhIP together with 0.5 or 0.125% HTHQ, 0.5 or 0.125% HTHQ alone or basal diet for 32 weeks. A small number (1.1 +/- 1.1/rat) of colon
tumors were induced by
DMH treatment alone. After initiation with
DMH, the number of colon
tumors was greatly increased to 8.3 +/- 5.6 by the administration of
PhIP. Additional treatment with HTHQ dose-dependently decreased the multiplicity of
colon adenocarcinomas to 4.9 +/- 2.8 and 2.6 +/- 1.4 with 0.125 and 0.5%, respectively. This treatment similarly reduced atypical
hyperplasias of the ventral prostate. Furthermore, HTHQ significantly reduced the multiplicity of duodenal
adenocarcinomas induced by
DMH +
PhIP or
DMH alone. Immunohistochemically, HTHQ was revealed to suppress
PhIP-DNA adduct formation in the epithelial cells of the colon and prostate in a separate 2 weeks experiment. The present results clearly showed that HTHQ has chemopreventive potential for
PhIP-associated colon and prostate
carcinogenesis. The observed inhibition may largely be due to interference with
PhIP-DNA adduct formation. In addition, HTHQ has been demonstrated to inhibit duodenal
carcinogenesis in the post-initiation stage.